Beiersdorf Aktiengesellschaft (OTCMKTS:BDRFF) Receives Average Rating of “Reduce” from Analysts

Beiersdorf Aktiengesellschaft (OTCMKTS:BDRFF) has received a consensus recommendation of “Reduce” from the six research firms that are covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation and four have given a hold recommendation to the company.

A number of research firms have issued reports on BDRFF. UBS Group upgraded Beiersdorf Aktiengesellschaft from a “sell” rating to a “neutral” rating in a report on Tuesday, March 31st. Berenberg Bank reiterated a “hold” rating on shares of Beiersdorf Aktiengesellschaft in a report on Monday, March 23rd. JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Beiersdorf Aktiengesellschaft in a report on Wednesday, March 18th. Morgan Stanley downgraded Beiersdorf Aktiengesellschaft from an “equal weight” rating to an “underweight” rating in a report on Monday, March 16th. Finally, Royal Bank Of Canada downgraded Beiersdorf Aktiengesellschaft from a “sector perform” rating to an “underperform” rating in a report on Tuesday, March 10th.

Beiersdorf Aktiengesellschaft Price Performance

Shares of Beiersdorf Aktiengesellschaft stock opened at $82.62 on Friday. The company’s fifty day simple moving average is $84.67 and its two-hundred day simple moving average is $98.49. Beiersdorf Aktiengesellschaft has a 12-month low of $79.77 and a 12-month high of $135.52.

About Beiersdorf Aktiengesellschaft

Beiersdorf Aktiengesellschaft is a global consumer goods company headquartered in Hamburg, Germany, with a history dating back to its founding in 1882 by pharmacist Paul C. Beiersdorf. The company is best known for its skincare brands, including NIVEA, Eucerin, La Prairie and Labello, as well as its tesa division, which produces self-adhesive products and industrial tapes. Over its long history, Beiersdorf has built a reputation for innovation in dermatological research and product development, introducing pioneering formulations that span mass-market and premium segments.

The company’s operations are organized into two main business divisions.